Journal of Kermanshah University of Medical Sciences

Published by: Neoscriber Demo Publisher
Crossmark
Uncorrected Proof scheduled for 23 (2)

Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study

Fariba Keramat 1 , 2 , Hamid Reza Ghasemi Basir ORCID 3 , * , Samira Ahmadpour 4 and Abbas Moradi 5
Authors Information
1 Brucellosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Infectious Diseases, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3 Department of Pathology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4 School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
5 Department of Community of Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Article information
  • Journal of Kermanshah University of Medical Sciences: In Press (In Press); e84967
  • Published Online: May 8, 2019
  • Article Type: Research Article
  • Received: October 5, 2018
  • Revised: March 2, 2019
  • Accepted: March 5, 2019
  • DOI: 10.5812/jkums.84967

To Cite: Keramat F, Ghasemi Basir H R, Ahmadpour S, Moradi A. Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study, J Kermanshah Univ Med Sci. Online ahead of Print ; In Press(In Press):e84967. doi: 10.5812/jkums.84967.

Abstract
Copyright © 2019, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, et al. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS. 2010;24(12):1867-76. doi: 10.1097/QAD.0b013e32833adbcf. [PubMed: 20467286]. [PubMed Central: PMC3018341].
  • 2. Kee MK, Lee JH, Kim EJ, Lee J, Nam JG, Yoo BH, et al. Improvement in survival among HIV-infected individuals in the Republic of Korea: Need for an early HIV diagnosis. BMC Infect Dis. 2009;9:128. doi: 10.1186/1471-2334-9-128. [PubMed: 19671189]. [PubMed Central: PMC2738677].
  • 3. Lane HC, Fauci AS. Human immunodeficiency virus disease: AIDS and related disorders. In: Fauci AS , Kasper DL , editors. Human immunodeficiency virus disease. New York: McGraw-Hill; 2012. p. 1137-203.
  • 4. World Health Organization. HIV/AIDS. 2014. Available from: http://www.who.int/mediacentre/factsheets/fs360/en/.
  • 5. Henle W, Henle G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res. 1981;41(11 Pt 1):4222-5. [PubMed: 6272966].
  • 6. Abdollahi A, Shoar S, Rasoulinejad M, Sheikhbahaei S. Seroprevalence of Epstein-Barr virus among HIV positive patients moreover and its association with CD4 positive lymphocyte count. Acta Med Iran. 2014;52(12):916-21. [PubMed: 25530055].
  • 7. He N, Chen L, Lin HJ, Zhang M, Wei J, Yang JH, et al. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends. 2011;5(1):1-9. [PubMed: 21422594].
  • 8. Alebouyeh M, Peller P, Goetz O, Ameri MA. [Comparative study of the prevalence of Epstein-Barr virus infections in Iran and Germany]. Monatsschr Kinderheilkd. 1984;132(11):850-1. German. [PubMed: 6096701].
  • 9. Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, White ZS, et al. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2003;37(9):1244-9. doi: 10.1086/378808. [PubMed: 14557970].
  • 10. Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007;60(12):1365-72. doi: 10.1136/jcp.2007.051953. [PubMed: 18042692]. [PubMed Central: PMC2095580].
  • 11. Kumar V, Cortran RS, Robbins SL. Basic pathology (general pathology). 6th ed. Philadelphia: Saunders; 2003. p. 147-58.
  • 12. Hal BJ. Epstein-Barr virus. In: Kliegman RM, Stanton BMD, Geme JS, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: WB Saunders; 2015.
  • 13. Abdollahi A, Irandoust I, Rasoulinejad M, Marzban M. [Frequency of EBV infection in HIV positives patients]. Armaghan Danesh. 2014;19(9):748-58. Persian.
  • 14. Fellner MD, Durand K, Correa RM, Redini L, Yampolsky C, Colobraro A, et al. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Int J Infect Dis. 2007;11(2):172-8. doi: 10.1016/j.ijid.2006.04.001. [PubMed: 16931088].
  • 15. Boutboul F, Puthier D, Appay V, Pelle O, Ait-Mohand H, Combadiere B, et al. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS. 2005;19(17):1981-6. [PubMed: 16260904].
  • 16. Roos MT, van Lier RA, Hamann D, Knol GJ, Verhoofstad I, van Baarle D, et al. Changes in the composition of circulating CD8+ T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis. 2000;182(2):451-8. doi: 10.1086/315737. [PubMed: 10915075].
  • 17. Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: Correlation with antiretroviral therapy and quantitative EBV serology. AIDS. 2002;16(7):993-1001. [PubMed: 11953465].
  • 18. Dias EP, Israel MS, Silva Junior A, Maciel VA, Gagliardi JP, Oliveira RH. Prevalence of oral hairy leukoplakia in 120 pediatric patients infected with HIV-1. Braz Oral Res. 2006;20(2):103-7. [PubMed: 16878201].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments